Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| The Use of Machine Learning to predict if patients with Renal Cancer will surivive or not | Vineel Ramineni | Academies of Loudoun | PLCO | Feb 27, 2023 | PLCO-1169 |
| Blood-based biomarkers for risk assessment and early detection of colorectal cancers | Samir Hanash | University of Texas MD Anderson Cancer Center | PLCO | Feb 23, 2023 | 2022-0046 |
| Carcinikos - Presentiment of Cancer in Male using multi modal techniques | Ananthanagu U | PES University | PLCO | Feb 21, 2023 | PLCO-1168 |
| Instrumental Variables Methods Reconcile Disparate Intention-to-Treat Effects Across Pragmatic Trials | Joshua Angrist | Massachusetts Institute of Technology | PLCO | Feb 8, 2023 | PLCO-1162 |
| AI Model for Predicting Outcomes in Incidences of Colorectal Cancer. | Siofra Murdoch | Harvard University | PLCO | Feb 8, 2023 | PLCO-1161 |
| Validation of a Self-Supervised Model for Tumor Recognition and Generalizability using the PLCO Cancer Screening Trial Dataset | Addie Dvir | Imagene | PLCO | Feb 8, 2023 | PLCOI-1158 |
| Other cancer incidence in PLCO | Ellen Chang | GRAIL, LLC | PLCO | Feb 8, 2023 | PLCO-1157 |
| A Machine Learning Model to Identify Patients at Risk for Developing Lung Cancer | Janakiraman Subramanian | Inova Health System | PLCO | Feb 8, 2023 | PLCO-1154 |
| Pilot study of air pollution adducts in PLCO serum samples | Katherine McGlynn | National Cancer Institute | PLCO | Feb 2, 2023 | 2023-9000 |
| Infection and immunity in uterine corpus and ovarian cancers | Kara Michels | Albert Einstein College of Medicine | PLCO | Feb 1, 2023 | 2022-0037 |
| Perfluorooctanoic acid (PFOA) exposure, DNA methylation patterns, and renal cell carcinoma | Charles Breeze | National Cancer Institute | PLCO | Jan 19, 2023 | 2022-0036 |
| Role of Cyanobacteria and cyanotoxins in liver cancer development | Brenda Hernandez | University of Hawaii Cancer Center | PLCO | Jan 19, 2023 | 2022-0033 |
| Missing censoring indicators in survival analysis | Mikael Escobar-Bach | Laboratoire Angevin de Recherche en Mathématiques, Université d'Angers | PLCO | Jan 18, 2023 | PLCO-1149 |
| Ovarian Cancer Detection using Menstruation and Weight/Calorie Tracking | Kavin Mohan | Queen's University | PLCO | Jan 13, 2023 | PLCO-1146 |
| A Deep Learning Algorithm using the PLCO data to estimate cancer risk from multiple cancers | Ping Hu | National Cancer Institute | PLCO | Jan 12, 2023 | PLCO-1142 |
| Research gaps in PSA tests and race-specific risk factors | Anwar Ahmed | Uniformed Services University | PLCO | Jan 11, 2023 | PLCO-1141 |
| Analysing non-clinical attributes of Male Breast Cancer using Machine Learning | Vaidehi Gajera | Western Sydney University | PLCO | Jan 11, 2023 | PLCO-1143 |
| Prostate Cancer Clinical Outcomes | K.C Balaji | UF Health Jacksonville | PLCO | Jan 3, 2023 | PLCO-1139 |
| Spatial and socioeconomic disparity in the colorectal cancer screening rate | Yoshito Nishimura | University of Hawaii | PLCO | Dec 27, 2022 | PLCO-1135 |
| Computational Pathology in Ovarian Cancer | Sandra Orsulic | Regents University of California Los Angeles | PLCO | Dec 19, 2022 | PLCOI-1132 |